Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) and Stevanato Group (NYSE:STVN – Get Free Report) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.
Valuation & Earnings
This table compares Guardian Pharmacy Services and Stevanato Group”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Guardian Pharmacy Services | $1.46 billion | 1.43 | $49.22 million | $0.83 | 50.31 |
| Stevanato Group | $1.20 billion | 5.08 | $158.21 million | €0.59 | 34.22 |
Risk & Volatility
Guardian Pharmacy Services has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500.
Profitability
This table compares Guardian Pharmacy Services and Stevanato Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Guardian Pharmacy Services | 3.64% | 30.72% | 15.99% |
| Stevanato Group | 11.76% | 10.27% | 6.08% |
Analyst Ratings
This is a breakdown of current ratings and target prices for Guardian Pharmacy Services and Stevanato Group, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Guardian Pharmacy Services | 0 | 2 | 7 | 0 | 2.78 |
| Stevanato Group | 0 | 2 | 2 | 2 | 3.00 |
Guardian Pharmacy Services presently has a consensus price target of $42.83, suggesting a potential upside of 2.57%. Given Guardian Pharmacy Services’ higher possible upside, analysts clearly believe Guardian Pharmacy Services is more favorable than Stevanato Group.
Summary
Guardian Pharmacy Services beats Stevanato Group on 7 of the 13 factors compared between the two stocks.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
